Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Conditions

Diseases of the Cardiovascular System

Volunteers
Health Professionals

What is the purpose of this trial?

The objective of this study is to determine the safety and efficacy of transcatheter aortic valve replacement (TAVR) via a transfemoral approach in HF patients with moderate AS as compared with OHFT.

Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Trial with
Boston Biomedical, Inc.
Start Date
10/26/2017
End Date
12/31/2021

For more information about this study, contact:

Sarah McManus

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

John K Forrest, MD, FACC, FSCAI
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine

Sub-Investigators

Last Updated
11/15/2022
Study HIC
#2000021341

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information